LAUNXP Biomedical Co., Ltd
LAUNXP Biomedical Co., Ltd engages in the research and development of drugs for cancer patients. It develops various drugs, which are in preclinical stage, including LXP5948 for non-small cell lung cancer and Alzheimer's disease; LXP5268 for triple negative breast cancer; LXP5101 for pancreatic cancer; LXP1788 for gastrointestinal cancer; and Virus-like particles for cancer and genetic defect tre… Read more
Market Cap & Net Worth: LAUNXP Biomedical Co., Ltd (6876)
LAUNXP Biomedical Co., Ltd (TWO:6876) has a market capitalization of $35.94 Million (NT$1.19 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #45464 globally and #2017 in its home market, demonstrating a 11.99% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LAUNXP Biomedical Co., Ltd's stock price NT$24.75 by its total outstanding shares 48046543 (48.05 Million).
LAUNXP Biomedical Co., Ltd Market Cap History: 2026 to 2026
LAUNXP Biomedical Co., Ltd's market capitalization history from 2026 to 2026. Data shows growth from $35.94 Million to $35.94 Million (0.00% CAGR).
LAUNXP Biomedical Co., Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LAUNXP Biomedical Co., Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6876 by Market Capitalization
Companies near LAUNXP Biomedical Co., Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to LAUNXP Biomedical Co., Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
LAUNXP Biomedical Co., Ltd Historical Marketcap From 2026 to 2026
Between 2026 and today, LAUNXP Biomedical Co., Ltd's market cap moved from $35.94 Million to $ 35.94 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$35.94 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of LAUNXP Biomedical Co., Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.94 Million USD |
| MoneyControl | $35.94 Million USD |
| MarketWatch | $35.94 Million USD |
| marketcap.company | $35.94 Million USD |
| Reuters | $35.94 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.